Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247377 · ClinicalTrials.gov registry record · NA
Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
A NA study of Morbid Obesity, sponsored by University of California, Irvine.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
- 1
- Study location
NCT00247377: Completed NA study of Morbid Obesity, sponsored by University of California, Irvine.
NCT00247377 is a NA study of Morbid Obesity that has completed, run by University of California, Irvine. The registered enrollment target is 197 participants, above the 114-participant average among 24 other Morbid Obesity trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00247377, a NA study of Morbid Obesity, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
- 1
- Study location
Study Summary
PURPOSE Obesity is a growing problem in the United States. Severe obesity, known as "morbid obesity", is defined as being 100 pounds in excess of ideal body weight. Nonsurgical treatments for morbid obesity include exercise, dietary restriction, behavior modification, and pharmacological intervention. However, it is estimated that most patients undergoing nonsurgical treatments for weight reduction will regain their weight within 2 to 4 years after treatment. According to the NIH consensus conference in 1991, surgery remains the only effective sustained weight loss treatment for morbid obesity. The Roux-en-Y gastric bypass (GBP) is currently considered the gold standard bariatric surgical operation. Mean weight loss following GBP is approximately 65% of the excess body weight during the first 12 to 18 months postoperatively. Long-term weight loss is in the range of 55-70% of excess body weight loss. Recently, the laparoscopic approach to GBP was reported. Wittgrove and colleagues reported their results of 75 patients who underwent laparoscopic GBP and demonstrated significant short-term advantages with comparable weight loss and reversal of comorbidities compared to the open approach. However, GBP might it be done laparoscopic or open approach can potentially be associated with significant morbidity and mortality such as anastomotic leak, pulmonary embolism, bowel obstruction, and postoperative stricture. The FDA recently approved the laparoscopic adjustable banding system (LAP-BAND) for use in the United States in June 2001. The LAP-BAND system is a device designed to induce weight loss in severely obese patients. It is surgically placed around the proximal stomach to create a small proximal stomach pouch and restricted opening, or stoma, through which passage of food will be slowed. An inflatable portion along the inner aspect of the band is connected to an access port, placed intramuscularly. This enabled stoma adjustments to be made without the need for furthe
Primary Outcome
weight loss as measured by change in percent of excess body weight
Conditions Studied
Interventions
- PROCEDURE Gastric bypass surgery
- PROCEDURE Lap-Band
Study Locations (1)
California
- Univeristy of California, Irvine, Medical Center - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2002-10 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00247377 record still lists
NCT00247377 is an interventional study that assigns participants to a tested intervention. The registered 197 participants enrollment target is mid-sized for trials with a published cap, above the 114-participant average among 24 other Morbid Obesity trials with a reported enrollment target (73% higher).
The record links to 1 condition, with Morbid Obesity appearing as the primary indexed condition, and to 2 interventions - of which Gastric bypass surgery is the first listed.
NCT00247377 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00247377 about?
NCT00247377 is a clinical study titled "Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity". PURPOSE Obesity is a growing problem in the United States. Severe obesity, known as "morbid obesity", is defined as being 100 pounds in excess of ideal body weight. Nonsurgical treatments for morbid obesity include exercise, dietary restriction, behavior modification, and pharmacological interventio...
What is the current status of trial NCT00247377?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2002-10. Estimated completion is 2009-12.
What conditions does trial NCT00247377 study?
This clinical trial studies the following conditions: Morbid Obesity.
What interventions are being tested in trial NCT00247377?
The interventions under investigation include: Gastric bypass surgery (PROCEDURE), Lap-Band (PROCEDURE).
Who is sponsoring clinical trial NCT00247377?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00247377 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morbid Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00247377's enrollment target sits among peer trials
197 5th of 24 higher than 20 of 24 other Morbid Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Morbid Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)
RECRUITING · NA
-
Activity Level Monitoring Study
ACTIVE NOT RECRUITING · NA
-
Effect of Macrocomposition on Nonalcoholic Fatty Liver Disease (NAFLD) in Bariatric Surgery Candidates
COMPLETED · NA
-
Laparoscopic Adjustable Gastric Banding as a Treatment for Morbid Obesity in Adolescents
COMPLETED · NA
-
Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women
COMPLETED · NA
-
Utilization of Very Low Calorie Diet in Obese General Surgery Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04219254 · 197 participants · Phase 1
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
- NCT06173778 · 197 participants · Phase 2
Semaglutide for Post-Smoking Cessation Weight Management
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia